Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

IKT Inhibikase Therapeutics Inc

3,27

0,11 (3,48%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Inhibikase Therapeutics (NASDAQ:IKT)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Inhibikase Therapeutics Charts.

Inhibikase Therapeutics (NASDAQ:IKT)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Inhibikase Therapeutics Charts.

News Inhibikase Therapeutics Inc

Form EFFECT - Notice of Effectiveness
Freitag 6 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 5 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Donnerstag 5 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Dienstag 3 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Montag 18 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Montag 18 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Freitag 8 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Montag 28 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Montag 28 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 25 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 24 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Inhibikase Therapeutics Inc News-Artikel

BNP Paribas (QX)

Gold vs US Dollar

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen